Last updated: April 17, 2025
Sponsor: Anna Axelin
Overall Status: Completed
Phase
N/A
Condition
N/ATreatment
N/AClinical Study ID
NCT06683183
VARHA/12937/13.02.02/2024
Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
duration of pregnancy at least 29+0 weeks
single pregnancy
age at least 18 years
ability to participate in Finnish. No exclusion criteria
Study Design
Total Participants: 11
Study Start date:
February 19, 2025
Estimated Completion Date:
April 11, 2025
Connect with a study center
Turku University Hospital
Turku,
FinlandSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.